Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This was a prospective phase II study on patients with locally advanced rectal cancer or
local recurrence, to evaluate the pathological response and resectability of a neoadjuvant
treatment based on the use of a combined treatment with VMAT-SIB and two drugs chemotherapy (
XELOX).
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi IRCCS Azienda Ospedaliero-Universitaria di Bologna